These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16982469)

  • 1. Pharmacogenomics of colorectal cancer prevention and treatment.
    Nguyen H; Tran A; Lipkin S; Fruehauf JP
    Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in chemotherapy of colorectal cancer.
    Henriette Tanja L; Guchelaar HJ; Gelderblom H
    Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
    Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
    J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
    Milano G
    Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
    Kweekel DM; Gelderblom H; Guchelaar HJ
    Cancer Treat Rev; 2005 Apr; 31(2):90-105. PubMed ID: 15847979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
    Braun MS; Quirke P; Seymour MT
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
    Cortejoso L; López-Fernández LA
    Pharmacogenomics; 2012 Jul; 13(10):1173-91. PubMed ID: 22909207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic contribution to drug response.
    Watson RG; McLeod HL
    Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).
    Aiello M; Vella N; Cannavò C; Scalisi A; Spandidos DA; Toffoli G; Buonadonna A; Libra M; Stivala F
    Mol Med Rep; 2011; 4(2):203-8. PubMed ID: 21468552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
    Lee W; Lockhart AC; Kim RB; Rothenberg ML
    Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
    Marshall JL; Gehan EA
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
    Kruzelock RP; Short W
    Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
    [No Abstract]   [Full Text] [Related]  

  • 18. Using genetic variation to optimize cancer chemotherapy.
    McLeod HL; Papageorgio C; Watters JW
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of colorectal cancer genetics.
    Gryfe R
    Surg Oncol Clin N Am; 2009 Oct; 18(4):573-83. PubMed ID: 19793566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.